Rubius Therapeutics

Ensemble Discovery is a biotechnology company focused on developing innovative therapeutics and bioassays through its proprietary DNA-Programmed Chemistry (DPC) platform. This cutting-edge technology allows for unprecedented control of chemical reactions, paving the way for novel therapeutic classes and advanced detection methods in drug discovery and diagnostics. The company's therapeutic arm is dedicated to creating Programmed Macrocycles aimed at challenging targets, while its detection platform specializes in Programmed Bioassays that sense protein functionality and disease markers. Ensemble's work holds significant potential for cancer diagnostics and treatment predictions, particularly regarding key proteins involved in various malignancies. Generated from the website

Claritas Genomics is a biotechnology company based in Cambridge, MA that specializes in genetic testing and diagnostics. With a focus on providing accurate and timely results, Claritas Genomics aims to support healthcare providers in making informed decisions for patient care. Generated from their business information